Abstract:Abstract Title: Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome or Serum Metabolomic Profile in Obese Girls with Polycystic Ovary Syndrome Background: The gut microbiome is altered in obese adolescents with polycystic ovary syndrome (PCOS), and is associated with free testosterone, metabolic markers and insulin resistance. Combined oral contraceptives (OCP) are a primary treatment for PCOS and lower testosterone, but it was unknown if they changed the gut microbiome in obese adolescents with PCOS. Objective: Assess the gut microbiome profile, targeted serum metabolomics, hormonal and metabolic measures in adolescents with PCOS and obesity with and without OCP treatment. Methods: Adolescent girls with PCOS and obesity with and without PCOS were recruited from a tertiary referral hospital and underwent stool and fasting blood collection, an oral glucose tolerance test and MRI for hepatic fat fraction. Fecal bacterial were profiled by high throughput 16S rRNA gene sequencing and fasting serum metabolomics performed with mass spectroscopy. Groups were compared with t-tests and correlations performed. Results: Twenty-nine obese adolescents with PCOS [Untreated N=21, 16±1.2 years, BMI%ile 36.5± 3.0; OCP N=8, 15.5±0.9, BMI%ile 32.5±3.9] participated. OCP therapy had lower free testosterone and higher SHBG (p<0.001). Platelets were significantly higher (p=0.01), along with a trend in elevated CRP (p=0.09) in the OCP group. There was no difference in measures of fasting glucose, insulin or lipids. Measures of insulin resistance including HOMA-IR and Matsuda were also similar. Principle components analysis of the serum metabolome was not different between the groups. Girls treated with OCP had similar stool microbiome α-diversity measures of bacterial evenness (p=0.28), bacterial diversity (p=0.15), and global microbial composition (β-diversity, p=0.56). Further, the percent relative abundance (%RA) of the Firmicutes: Bacteroidetes ratio was similar, as well as the %RA at the phyla, family and genus level. Bacterial α-diversity was negatively associated with serum bile acids and branched chain amino acids. A higher %RA of family Ruminococcaceae was significantly associated with serum conjugated bile acids and HOMA-IR. Conclusion: Despite changes in free testosterone and SHBG, adolescent girls with PCOS treated with OCP had similar clinical and gut microbiome profile compared to the untreated PCOS group. The significant association between bacterial α-diversity, Ruminococcaceae, clinical markers and bile acids suggests a potential role of the gut microbiome in the pathogenesis of metabolic syndrome and PCOS.

Combined oral contraceptives and mental health: Are adolescence and the gut-brain axis the missing links?

Molecular brain signatures of oral contraceptives and implications for risk for depressive episodes

Hormonal Contraceptives and the Brain - Implications for Women's Mental Health

Hormonal contraceptive intake during adolescence and cortical brain measures in the ABCD Study

The Oral Contraceptive Pill and Adolescents' Mental Health

Oral Contraceptives and the Risk of Psychiatric Side Effects: A Review

The gut microbiota, HPA axis, and brain in adolescent-onset depression: Probiotics as a novel treatment

Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome

Beyond Birth Control: The Neuroscience of Hormonal Contraceptives

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Effect of oral contraceptives on energy balance in women: A review of current knowledge and potential cellular mechanisms

Gut-brain axis: A matter of concern in neuropsychiatric disorders ...!

Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome or Serum Metabolomic Profile in Obese Girls with Polycystic Ovary Syndrome

Reduced threat avoidance but increased stress induced approach bias in women taking oral contraceptives

Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls

Enduring sex-dependent implications of pubertal stress on the gut-brain axis and mental health

Health benefits of combined oral contraceptives – a narrative review

Combined estrogen-progestin oral contraceptives and female sexuality: an updated review

Starting the pill during adolescence: Age of onset and duration of use influence morphology of the hippocampus and ventromedial prefrontal cortex

Gynecologic and reproductive health concerns of adolescents using selected psychotropic medications

The role of combined oral contraceptives in the management of acne and seborrhea